Iradimed (IRMD) EPS (Basic) (2013 - 2026)

Iradimed (IRMD) has 14 years of EPS (Basic) data on file, last reported at $0.46 in Q1 2026.

• On a quarterly basis, EPS (Basic) rose 23.46% year-over-year to $0.46 in Q1 2026; TTM through Mar 2026 was $1.84, a 22.65% increase from a year earlier, with the FY2025 full-year figure at $1.76, up 20.38% from the prior year.
• EPS (Basic) for Q1 2026 stood at $0.46, down from $0.5 in the prior quarter.
• Over the last five years, EPS (Basic) for IRMD reached as high as $0.5 in Q4 2025 and fell as low as $0.2 in Q1 2022.
• Historically, EPS (Basic) has averaged $0.35 across 5 years, with a median of $0.35 in 2024.
• Across the five-year window, EPS (Basic) soared 116.18% in 2022 and decreased 16.86% in 2023, its largest moves.
• Year by year, EPS (Basic) stood at $0.3 in 2022, then dropped by 16.86% to $0.25 in 2023, then surged by 41.93% to $0.35 in 2024, then jumped by 42.54% to $0.5 in 2025, then fell by 9.06% to $0.46 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $0.46 in Q1 2026, $0.5 in Q4 2025, and $0.44 in Q3 2025.